Article
Waikoloa, Hawaii - Phase III trials show etanercept (Enbrel, Amgen Inc. and Wyeth) has efficacy and safety for moderate to severe psoriasis.
Bridging Dermatology and Psychological Support
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Tailoring Atopic Dermatitis Treatment to Meet Patient Needs
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
How Well Revolution Combines In-Person Care with Telehealth
Potential 2025 Tax Law Changes: What Dermatologists Should Know